Cellebrite DI Cash Flow-to-Debt Ratio
Cellebrite DI cash flow-to-debt ratio. Cellebrite DI (CLBT) has a Cash Flow-to-Debt Ratio of 0.18x as of December 2025, meaning its operating cash flow of $82.23 Million could theoretically repay 0% of its total liabilities ($454.53 Million) in one year. Check CLBT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cellebrite DI (2019–2025)
Cash flow-to-debt ratio of Cellebrite DI from 2019 to 2025. Historical debt coverage capacity for Cellebrite DI across 7 annual periods. Check Cellebrite DI investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Cellebrite DI Cash Flow-to-Debt Ratio by Year (2019–2025)
Cellebrite DI cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Cellebrite DI. For the full cash flow conversion analysis, see CLBT operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | $168.96 Million | $454.53 Million | ▼ -0.3% |
| 2024 | 0.37x | $132.17 Million | $354.55 Million | ▲ +82.2% |
| 2023 | 0.20x | $102.06 Million | $498.67 Million | ▲ +227.6% |
| 2022 | 0.06x | $20.58 Million | $329.43 Million | ▼ -28.4% |
| 2021 | 0.09x | $36.05 Million | $413.13 Million | ▼ -60.6% |
| 2020 | 0.22x | $66.51 Million | $300.58 Million | ▲ +203.7% |
| 2019 | 0.07x | $16.13 Million | $221.41 Million | — |